Novel Clinically Translatable Iron Oxide Nanoparticle for Monitoring Anti-CD47 Cancer Immunotherapy

From the Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, CA (R.R., L.P., F.P., L.K., H.E.D.-L.); and Department of Pediatrics, Hematology/Oncology, Stanford University School of Medicine, Stanford, CA (H.E.D.-L.).

Received for publication June 1, 2023; and accepted for publication, after revision, August 21, 2023.

Conflicts of interest: none declared.

This work was supported by a grant from the National Cancer Institute (grant number U24CA264298 [principal investigator Heike E. Daldrup-Link]). The small animal imaging and biomedical statistics research resources used for this project were supported by the Stanford Cancer Institute (P30CA124435 grant [principal investigator Steven Artandi] from the National Cancer Institute).

Correspondence to: Heike E. Daldrup-Link, MD, PhD, Department of Radiology, Lucile Packard Children's Hospital, Stanford School of Medicine, 725 Welch Rd, CA 94305-5654. E-mail: [email protected].

Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.investigativeradiology.com).

留言 (0)

沒有登入
gif